Teleflex (TFX) Total Current Liabilities (2009 - 2026)
Teleflex's (TFX) quarterly Total Current Liabilities came in at $720.4 million in Q2 2026, up 0.59% on a YoY basis from $716.1 million in Q2 2025, and down 1.05% quarter-over-quarter from $728.0 million in Q1 2026.
Analysis
Teleflex (TFX) Total Current Liabilities (2009 - 2026) Analysis & Trends
Teleflex (TFX) has reported Total Current Liabilities for 18 consecutive years, with $720.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities rose 0.59% year-over-year to $720.4 million; the trailing twelve-month figure through Jun 2026 stood at $720.4 million (up 0.59% YoY), and the FY2025 full-year result was $762.0 million, up 17.35% from the prior year.
- Total Current Liabilities slipped to $720.4 million in Q2 2026 per TFX's latest filing, from $728.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $773.0 million in Q3 2025 and bottomed at $555.4 million in Q3 2023.
- Historically, Total Current Liabilities has averaged $641.9 million across 5 years, with a median of $614.8 million in 2022.
- The widest YoY moves for Total Current Liabilities: up 29.16% in 2022, down 14.5% in 2022.
- Over 5 years, Total Current Liabilities stood at $581.5 million in 2022, then rose by 4.34% to $606.7 million in 2023, then rose by 7.02% to $649.4 million in 2024, then climbed by 17.35% to $762.0 million in 2025, then declined by 5.47% to $720.4 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $720.4 million, $728.0 million, and $762.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 11.80 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 6.68 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 6.43 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 1.51 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 3.17 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.36 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Teleflex | 5.76 Bn | 5.46 Bn | 331.71 Mn | 720.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 720.38 Mn |
| Mar 31, 2026 | 728.05 Mn |
| Dec 31, 2025 | 762.03 Mn |
| Sep 28, 2025 | 773.03 Mn |
| Jun 29, 2025 | 716.15 Mn |
| Mar 30, 2025 | 675.91 Mn |
| Dec 31, 2024 | 649.36 Mn |
| Sep 29, 2024 | 618.75 Mn |
| Jun 30, 2024 | 556.75 Mn |
| Mar 31, 2024 | 571.01 Mn |
| Dec 31, 2023 | 606.75 Mn |
| Oct 1, 2023 | 585.42 Mn |
| Jul 2, 2023 | 555.45 Mn |
| Apr 2, 2023 | 575.71 Mn |
| Dec 31, 2022 | 581.49 Mn |
| Sep 25, 2022 | 610.94 Mn |
| Jun 26, 2022 | 610.45 Mn |
| Mar 27, 2022 | 656.20 Mn |
| Dec 31, 2021 | 680.12 Mn |
| Sep 26, 2021 | 562.21 Mn |